Volume pricing
| Quantity | Per vial | Save |
|---|---|---|
| 1–4 | 47.50 USDT | — |
| 5–9 | 45.00 USDT | 5% |
| 10–24 | 42.00 USDT | 12% |
| 25–49 | 39.00 USDT | 18% |
| 50+ | 35.50 USDT | 25% |
Retatrutide
For Research Use Only · Not for Human Consumption
Weight lossMetabolic
Retatrutide is an investigational tri-agonist peptide engaging GIP, GLP-1 and glucagon receptors. Preclinical research explores combined receptor activation on lipolysis, thermogenesis and hepatic glucose output. Supplied as lyophilized powder at ≥98% HPLC purity. For Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Potential benefits — preclinical research
- •~23% mean body-weight reduction in mid-stage trials — the largest reported for any incretin to date.
- •Triple GIP / GLP-1 / glucagon receptor agonism uniquely targets fat oxidation alongside satiety.
- •Improvements in liver fat, insulin sensitivity and lipid panels in preclinical studies.
- •Reduced knee pain and improved physical function reported in obesity sub-studies.
Findings reported in published in-vitro / animal studies. Not therapeutic claims — for research use only.
Certificate of Analysis
View certificate⏱Ships within 15 days — made to order
47.50 USDTper vial
≈ €43.70